Funmilayo O. Ajayi,
PhD, FIST, FCP
Annesway Group, LLC
Funmi was a National Research Council Resident Research Fellow at Walter Reed Army Institute of Research prior to a 10-year tenure at the Center for Drug Evaluation and Research (CDER), FDA and 14 years with Procter & Gamble (P&G). As a Clinical Pharmacology & Biopharmaceutics Team Leader for the Division of Special Pathogens and Immunologic Drug Products, Funmi led regulatory review of applications for anti-infective, special pathogens & immunologic drug products and, was heavily involved in the development of regulatory guidance documents. She was 2-term chair of FDA CDER’s Committee for Advanced Scientific Education (CASE). Funmi’s P&G career and responsibilities spanned an array of assignments as a leader in the Global Clinical & Quantitative Sciences Organization including strategic planning for clinical work for multiple business sectors in addition to leading the Global Safety Surveillance & Analysis and, the Global Clinical Governance & Compliance Organizations.
Funmi is a Fellow of the London Institute of Science Technology and a Fellow of the American College of Clinical Pharmacology where she served as chair of the Honors and Awards Committee and, Strategic Visions Committee, as well as member of the 2006 and 2012 Annual Program Committees. In addition, Funmi is a long-term reviewer for the Journal of Clinical Pharmacology.
She is a founding member of the Nigerian Association of Pharmacists & Pharmaceutical Scientists in the Americas (NAPPSA). In this role, she served as Secretary for 7 years and was President of the organization for 2 years. As adjunct professor, College of Pharmacy, University of Cincinnati, Funmi teaches a graduate program in drug development. She was Secretary and past Chair of Indiana/Ohio Discussion Group of the Association of American Pharmaceutical Scientists. Over the years, Funmi received several awards and recognition including CDER Director’s Special Citation; FDA Outstanding Service Award; Outstanding Contribution Award, FDA Alumni Association; CDER CASE 25th Anniversary Celebration Special Recognition Award; P&G Sharon Mitchell Glass Breaking Award; and P&G Community Beacon Award.
Scott Treiber, PhD MBA
Vice President, Strategic Development,
Synteract
Scott is an experienced clinical development professional with over 25 years of increasing responsibility in the biopharmaceutical industry. His expertise encompasses clinical operations, medical affairs, data management/statistics, pharmacovigilance and medical writing. Dr. Treiber has a strong background in neuroscience development but has also worked extensively in oncology/hematology, pain, women’s health, GI and respiratory.
Scott received his BA from the University of Iowa, his PhD from the University of California, Santa Cruz and his MBA from NYIT.
